Prevalence of Metabolic Syndrome and its influence on microvascular complications in the Indian population with Type 2 Diabetes Mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 14)

Table 6 Effect of duration of Diabetes on the prevalence of microangiopathies in study population with or without Metabolic Syndrome

		Prevalence of Microangiopathy
Variables	Groups	Duration (0-10 years)	p	Duration (11-20 years)	p	Duration (> 20 years)	p
Overall
Retinopathy	MS Absent	48 (28.2)	< 0.0001	25 (34.7)	0.013	6 (46.2)	1.000
	MS Present	122 (71.8)		47 (65.3)		7 (53.8)
Nephropathy	MS Absent	61 (29.6)	< 0.0001	12 (22.6)	< 0.0001	3 (60.0)	1.000
	MS Present	145 (70.4)		41 (77.4)		2 (40.0)
Neuropathy	MS Absent	38 (19.9)	< 0.0001	18 (31.0)	0.005	7 (46.7)	1.000
	MS Present	153 (80.1)		40 (69.0)		8 (53.3)
Men
Retinopathy	MS Absent	36 (34.3)	0.002	19 (43.2)	0.451	6 (66.7)	0.508
	MS Present	69 (65.7)		25 (56.8)		3 (33.3)
Nephropathy	MS Absent	46 (43.4)	0.206	11 (36.7)	0.200	3 (60.0)	1.000
	MS Present	60 (56.6)		19 (63.3)		2 (40.0)
Neuropathy	MS Absent	24 (24.2)	< 0.0001	16 (40.0)	0.268	6 (60.0)	0.754
	MS Present	75 (75.8)		24 (60.0)		4 (40.0)
Women
Retinopathy	MS Absent	12 (18.5)	< 0.0001	6 (21.4)	0.004	0 (0.0)	0.125
	MS Present	53 (81.5)		22 (78.6)		4 (100.0)
Nephropathy	MS Absent	15 (15.0)	< 0.0001	1 (4.3)	< 0.0001	0 (0.0)	NA
	MS Present	85 (85.0)		22 (95.7)		0 (0.0)
Neuropathy	MS Absent	14 (15.2)	< 0.0001	2 (11.1)	0.001	1 (20.0)	0.375
	MS Present	78 (84.8)		16 (88.9)		4 (80.0)